EY report warns medtech is moving too slowly

EY Life Sciences has published the 2018 edition of its annual Pulse of the Industry report looking ahead to the future of the medtech sector.

The report calls for more vision in the sector, and a move away from solely delivering short-term profit at the expense of ambitious long-term strategy. It predicts major structural shifts in the industry, particularly around utilisation of large data-sets and digital capabilities, and that companies which make best use of these as a resource, including for personalisation of medicine, will prevail.

The report highlights availability of funding for start-ups, and returns to investors though a thriving mergers and acquisitions environment, but stresses the need for companies to make best use of these favourable conditions by retaining focus on their key market objectives, and designing products and services which anticipate the future of medical practice.

Tagged with

Published on 25. September 2018 in News, News EU, News International, News UK